Therapeutic inhibition of USP7-PTEN network in chronic lymphocytic leukemia: a strategy to overcome TP53 mutated/deleted clones

Chronic Lymphocytic Leukemia (CLL) is a lymphoproliferative disorder with either indolent or aggressive clinical course. Current treatment regiments have significantly improved the overall outcomes even if higher risk subgroups - those harboring TP53 mutations or deletions of the short arm of chromo...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Oncotarget
Autors principals: Carrà, Giovanna, Panuzzo, Cristina, Torti, Davide, Parvis, Guido, Crivellaro, Sabrina, Familiari, Ubaldo, Volante, Marco, Morena, Deborah, Lingua, Marcello Francesco, Brancaccio, Mara, Guerrasio, Angelo, Pandolfi, Pier Paolo, Saglio, Giuseppe, Taulli, Riccardo, Morotti, Alessandro
Format: Artigo
Idioma:Inglês
Publicat: Impact Journals LLC 2017
Matèries:
Priority Research Paper
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5482594/
https://ncbi.nlm.nih.gov/pubmed/28418900
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.16348
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars